770 related articles for article (PubMed ID: 15557200)
1. Combinations of anti-LFA-1, everolimus, anti-CD40 ligand, and allogeneic bone marrow induce central transplantation tolerance through hemopoietic chimerism, including protection from chronic heart allograft rejection.
Metzler B; Gfeller P; Bigaud M; Li J; Wieczorek G; Heusser C; Lake P; Katopodis A
J Immunol; 2004 Dec; 173(11):7025-36. PubMed ID: 15557200
[TBL] [Abstract][Full Text] [Related]
2. Differential promotion of hematopoietic chimerism and inhibition of alloreactive T cell proliferation by combinations of anti-CD40Ligand, anti-LFA-1, everolimus, and deoxyspergualin.
Metzler B; Gfeller P; Wieczorek G; Katopodis A
Transpl Immunol; 2008 Nov; 20(1-2):106-12. PubMed ID: 18675355
[TBL] [Abstract][Full Text] [Related]
3. Prevention of chronic rejection in murine cardiac allografts: a comparison of chimerism- and nonchimerism-inducing costimulation blockade-based tolerance induction regimens.
Shirasugi N; Adams AB; Durham MM; Lukacher AE; Xu H; Rees P; Cowan SR; Williams MA; Pearson TC; Larsen CP
J Immunol; 2002 Sep; 169(5):2677-84. PubMed ID: 12193741
[TBL] [Abstract][Full Text] [Related]
4. Innate and adaptive immune responses are tolerized in chimeras prepared with nonmyeloablative conditioning.
Xu H; Zhu Z; Huang Y; Bozulic LD; Hussain LR; Yan J; Ildstad ST
Transplantation; 2012 Mar; 93(5):469-76. PubMed ID: 22228418
[TBL] [Abstract][Full Text] [Related]
5. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
Li JM; Gorechlad J; Larsen CP; Waller EK
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
[TBL] [Abstract][Full Text] [Related]
6. Tolerance induction through megadose bone marrow transplantation with two-signal blockade.
Lee EN; Lee J; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Kwon CH; Joh JW; Kim SJ
J Surg Res; 2006 Jan; 130(1):102-9. PubMed ID: 16183077
[TBL] [Abstract][Full Text] [Related]
7. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
[TBL] [Abstract][Full Text] [Related]
8. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
9. Viral abrogation of stem cell transplantation tolerance causes graft rejection and host death by different mechanisms.
Forman D; Welsh RM; Markees TG; Woda BA; Mordes JP; Rossini AA; Greiner DL
J Immunol; 2002 Jun; 168(12):6047-56. PubMed ID: 12055213
[TBL] [Abstract][Full Text] [Related]
10. Anti-OX40L monoclonal antibody prolongs secondary heart allograft survival based on CD40/CD40L and LFA-1/ICAM-1 blockade.
Dai H; Peng F; Lin M; Xia J; Yu S; Lan G; Wang Y; Xie X; Fang C; Corbascio M; Qi Z; Peng L
Transpl Immunol; 2015 Mar; 32(2):84-91. PubMed ID: 25613092
[TBL] [Abstract][Full Text] [Related]
11. T-regulatory cell treatment prevents chronic rejection of heart allografts in a murine mixed chimerism model.
Pilat N; Farkas AM; Mahr B; Schwarz C; Unger L; Hock K; Oberhuber R; Aumayr K; Wrba F; Wekerle T
J Heart Lung Transplant; 2014 Apr; 33(4):429-37. PubMed ID: 24468120
[TBL] [Abstract][Full Text] [Related]
12. Anti-LFA-1 or rapamycin overcome costimulation blockade-resistant rejection in sensitized bone marrow recipients.
Ramsey H; Pilat N; Hock K; Klaus C; Unger L; Schwarz C; Baranyi U; Gattringer M; Schwaiger E; Wrba F; Wekerle T
Transpl Int; 2013 Feb; 26(2):206-18. PubMed ID: 23240587
[TBL] [Abstract][Full Text] [Related]
13. Cutting edge: administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning.
Durham MM; Bingaman AW; Adams AB; Ha J; Waitze SY; Pearson TC; Larsen CP
J Immunol; 2000 Jul; 165(1):1-4. PubMed ID: 10861026
[TBL] [Abstract][Full Text] [Related]
14. Costimulation blockade, busulfan, and bone marrow promote titratable macrochimerism, induce transplantation tolerance, and correct genetic hemoglobinopathies with minimal myelosuppression.
Adams AB; Durham MM; Kean L; Shirasugi N; Ha J; Williams MA; Rees PA; Cheung MC; Mittelstaedt S; Bingaman AW; Archer DR; Pearson TC; Waller EK; Larsen CP
J Immunol; 2001 Jul; 167(2):1103-11. PubMed ID: 11441122
[TBL] [Abstract][Full Text] [Related]
15. Blockade of adhesion molecule lymphocyte function-associated antigen-1 improves long-term heart allograft survival in mixed chimeras.
Pilat N; Sabler P; Klaus C; Mahr B; Unger L; Hock K; Wiletel M; Schwarz C; Kristo I; Regele H; Wekerle T
J Heart Lung Transplant; 2018 Sep; 37(9):1119-1130. PubMed ID: 29699851
[TBL] [Abstract][Full Text] [Related]
16. Robust tolerance to fully allogeneic islet transplants achieved by chimerism with minimal conditioning.
Luo B; Nanji SA; Schur CD; Pawlick RL; Anderson CC; Shapiro AM
Transplantation; 2005 Aug; 80(3):370-7. PubMed ID: 16082333
[TBL] [Abstract][Full Text] [Related]
17. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
Pan Y; Luo B; Sozen H; Kalscheuer H; Blazar BR; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2003 Jul; 76(1):216-24. PubMed ID: 12865813
[TBL] [Abstract][Full Text] [Related]
18. Chimeric donor cells play an active role in both induction and maintenance phases of transplantation tolerance induced by mixed chimerism.
Kanamoto A; Maki T
J Immunol; 2004 Feb; 172(3):1444-8. PubMed ID: 14734720
[TBL] [Abstract][Full Text] [Related]
19. Anti-lymphocyte function-associated antigen-1 monoclonal antibody inhibits CD40 ligand-independent immune responses and prevents chronic vasculopathy in CD40 ligand-deficient mice.
Corbascio M; Mahanty H; Osterholm C; Qi Z; Pearson TC; Larsen CP; Freise CE; Ekberg H
Transplantation; 2002 Jul; 74(1):35-41. PubMed ID: 12134096
[TBL] [Abstract][Full Text] [Related]
20. CD40 ligand-specific antibodies synergize with cyclophosphamide to promote long-term transplantation tolerance across MHC barriers but inhibit graft-vs-leukemia effects of transplanted cells.
Prigozhina TB; Gurevitch O; Elkin G; Morecki S; Yakovlev E; Slavin S
Exp Hematol; 2003 Jan; 31(1):81-8. PubMed ID: 12543110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
